DCM
SUPN icon

Dupont Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Dupont Capital Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-18,850
Closed -$447K – 1372
2019
Q4 		$447K Sell
18,850
-15,194
-45% -$369K 0.01% 892
2019
Q3 		$936K Sell
34,044
-3,650
-10% -$108K 0.02% 546
2019
Q2 		$1.25M Hold
37,694
– – 0.03% 484
2019
Q1 		$1.32M Hold
37,694
– – 0.03% 474
2018
Q4 		$1.25M Buy
37,694
+7,073
+23% +$304K 0.03% 474
2018
Q3 		$1.54M Hold
30,621
– – 0.03% 452
2018
Q2 		$1.83M Hold
30,621
– – 0.04% 395
2018
Q1 		$1.4M Buy
30,621
+22,295
+268% +$930K 0.03% 418
2017
Q4 		$332K Hold
8,326
– – 0.01% 741
2017
Q3 		$333K Hold
8,326
– – 0.01% 749
2017
Q2 		$359K Buy
+8,326
New +$296K 0.01% 743
2016
Q4 		– Sell
-20,027
Closed -$495K – 867
2016
Q3 		$495K Sell
20,027
-61,674
-75% -$1.4M 0.01% 570
2016
Q2 		$1.66M Hold
81,701
– – 0.04% 331
2016
Q1 		$1.25M Buy
81,701
+18,287
+29% +$239K 0.03% 413
2015
Q4 		$852K Sell
63,414
-12,623
-17% -$195K 0.02% 499
2015
Q3 		$1.07M Hold
76,037
– – 0.03% 444
2015
Q2 		$1.29M Buy
76,037
+45,738
+151% +$651K 0.03% 402
2015
Q1 		$366K Hold
30,299
– – 0.01% 534
2014
Q4 		$251K Hold
30,299
– – ﹤0.01% 584
2014
Q3 		$263K Sell
30,299
-1,700
-5% -$15.4K ﹤0.01% 609
2014
Q2 		$350K Buy
31,999
+31,899
+31,899% +$284K 0.01% 605
2014
Q1 		$1K Hold
100
– – ﹤0.01% 622
2013
Q4 		$1K Buy
+100
New +$699 ﹤0.01% 597

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dupont Capital Management's SUPN Position: Q1 2020 in Review

Dupont Capital Management sold out of Supernus Pharmaceuticals (SUPN) in Q1 2020, closing a stake of 18,850 shares — an estimated $447K sold.

Dupont Capital Management first reported a position in SUPN in Q4 2013 and held it in 23 quarters. The position peaked at $1.83M in Q2 2018. 208 funds tracked by Wall St. Rank hold SUPN as of Q1 2020.

  • Dupont Capital Management reported no remaining Supernus Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Dupont Capital Management sold 18,850 Supernus Pharmaceuticals shares in Q1 2020, an estimated $447K.
  • Dupont Capital Management first reported a position in Supernus Pharmaceuticals in Q4 2013 and held it in 23 quarters.
  • Dupont Capital Management's Supernus Pharmaceuticals position peaked at $1.83M in Q2 2018.
  • 208 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2020.

Based on Dupont Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.